County

Pend Oreille County Emergency Medical Services

May be outdated202 dose entries51 drugs1 documentWAeffective 2021-11-01100% machine-parsed of 202

Pend Oreille County Emergency Medical Services (WA) carries 51 drugs across 202 dose entries in its current published protocol, effective 2021-11-01.

The current listed document is more than 24 months old and may be outdated.

Drugs and doses51

Acetaminophen

Indication	Population	Dose	Route	Repeat	Standing	Source
Fever	adult	650–1000 mg	PO/PR	not captured	standing	page 206
Fever	peds	15 mg/kg	PO/PR	not captured	standing	page 206
Mild to moderate pain	adult	650–1000 mg	PO/PR	not captured	standing	page 206
Mild to moderate pain	peds	15 mg/kg	PO/PR	not captured	standing	page 206

Activated Charcoal

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	25 g	PO	not captured	standing	page 268
Other	adult	25 g	PO	not captured	standing	page 268

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
SVT	adult	6 mg	IV/IO	not captured	standing	page 145
SVT	peds	0.1 mg/kg	IV/IO	not captured	standing	page 145
Wide-complex tachycardia	adult	6 mg	IV/IO	not captured	standing	page 148
Wide-complex tachycardia	peds	0.1 mg/kg	IV/IO	not captured	standing	page 148

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2.5 mg	NEB	not captured	standing	page 216
Asthma / bronchospasm	adult	2.5 mg	NEB	not captured	standing	page 216
Asthma / bronchospasm	peds	2.5 mg	NEB	not captured	standing	page 216
Asthma / bronchospasm	peds	2.5 mg	NEB	not captured	standing	page 216
Crush injury	adult	5 mg	NEB	not captured	standing	page 237
Crush injury	peds	5 mg	NEB	not captured	standing	page 237
Hyperkalemia	adult	5 mg	NEB	not captured	standing	page 168
Hyperkalemia	peds	5 mg	NEB	not captured	standing	page 168

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Wide-complex tachycardia	adult	150 mg	IV/IO	not captured	standing	page 149
Wide-complex tachycardia	peds	5 mg/kg	IV/IO	not captured	standing	page 149
VF / pulseless VT	adult	300 mg	IV/IO	not captured	standing	page 147
VF / pulseless VT	adult	300 mg	IV/IO	not captured	standing	page 147
VF / pulseless VT	peds	5 mg/kg	IV/IO	not captured	standing	page 147
VF / pulseless VT	peds	5 mg/kg	IV/IO	not captured	standing	page 147

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	324 mg	PO	not captured	standing	page 137

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	0.5 mg	IV/IO	not captured	standing	page 143
Bradycardia	peds	0.02 mg/kg	IV/IO	not captured	standing	page 143
Nerve agent exposure	adult	2 mg	IM	not captured	standing	page 172
Nerve agent exposure	peds	0.02–0.05 mg/kg	IM	not captured	standing	page 172
Organophosphate poisoning	adult	2 mg	IM	not captured	standing	page 172
Organophosphate poisoning	peds	0.02–0.05 mg/kg	IM	not captured	standing	page 172
RSI induction	peds	0.02 mg/kg	IV/IO	not captured	standing	page 85

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	500–1000 mg	IV/IO	not captured	standing	page 275
Beta-blocker / calcium-channel-blocker overdose	peds	10 mg/kg	IV/IO	not captured	standing	page 275
Burns	adult	500–1000 mg	IV/IO	not captured	standing	page 275
Burns	peds	10 mg/kg	IV/IO	not captured	standing	page 275
Crush injury	adult	500–1000 mg	IV/IO	not captured	standing	page 275
Crush injury	peds	10 mg/kg	IV/IO	not captured	standing	page 275
Hyperkalemia	adult	500–1000 mg	IV/IO	not captured	standing	page 275
Hyperkalemia	peds	10 mg/kg	IV/IO	not captured	standing	page 275
Other	adult	500–1000 mg	IV/IO	not captured	standing	page 275
Other	peds	10 mg/kg	IV/IO	not captured	standing	page 275

Calcium Gluconate

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	2000 mg	IV/IO	not captured	standing	page 276
Beta-blocker / calcium-channel-blocker overdose	peds	2–8 mL	IV/IO	not captured	standing	page 276
Crush injury	adult	2000 mg	IV/IO	not captured	standing	page 276
Crush injury	peds	2–8 mL	IV/IO	not captured	standing	page 276
Hyperkalemia	adult	2000 mg	IV/IO	not captured	standing	page 276
Hyperkalemia	peds	2–8 mL	IV/IO	not captured	standing	page 276
Other	adult	2000 mg	IV/IO	not captured	standing	page 276
Other	peds	2–8 mL	IV/IO	not captured	standing	page 276

Dexamethasone

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	4–10 mg	IV/IO/IM/PO	not captured	standing	page 277
Allergic reaction	peds	0.6 mg/kg	IV/IO/IM/PO	not captured	standing	page 277
Anaphylaxis	adult	4–10 mg	IV/IO/IM/PO	not captured	standing	page 277
Anaphylaxis	peds	0.6 mg/kg	IV/IO/IM/PO	not captured	standing	page 277
Asthma / bronchospasm	adult	4–10 mg	IV/IO/IM/PO	not captured	standing	page 277
Asthma / bronchospasm	adult	4–10 mg	IV/IO/IM/PO	not captured	standing	page 277
Asthma / bronchospasm	peds	0.6 mg/kg	IV/IO/IM/PO	not captured	standing	page 277
Asthma / bronchospasm	peds	0.6 mg/kg	IV/IO/IM/PO	not captured	standing	page 277
Croup	adult	4–10 mg	IV/IO/IM/PO	not captured	standing	page 277
Croup	peds	0.6 mg/kg	IV/IO/IM/PO	not captured	standing	page 277

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	adult	12.5–25 g	IV/IO	not captured	standing	page 278
Hyperkalemia	peds	1 g/kg	IV/IO	not captured	standing	page 278
Hypoglycemia	adult	12.5–25 g	IV/IO	not captured	standing	page 278
Hypoglycemia	peds	1 g/kg	IV/IO	not captured	standing	page 278
Other	adult	12.5–25 g	IV/IO	not captured	standing	page 278
Other	peds	1 g/kg	IV/IO	not captured	standing	page 278

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	5–10 mg	IV/IO	not captured	standing	page 279
Hypothermia	adult	5–10 mg	IV/IO	not captured	standing	page 279
Nerve agent exposure	adult	5–10 mg	IV/IO	not captured	standing	page 279
Organophosphate poisoning	adult	5–10 mg	IV/IO	not captured	standing	page 279
Other	adult	5–10 mg	IV/IO	not captured	standing	page 279
Seizure	adult	5–10 mg	IV/IO	not captured	standing	page 279

Diltiazem

Indication	Population	Dose	Route	Repeat	Standing	Source
Narrow-complex tachycardia	adult	0.25 mg/kg	IV/IO	not captured	standing	page 280

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	12.5–50 mg	IV/IO/IM	not captured	standing	page 281
Allergic reaction	peds	1 mg/kg	IV/IO/IM	not captured	standing	page 281
Anaphylaxis	peds	1 mg/kg	IV/IO/IM	not captured	standing	page 281
Dystonic reaction	peds	1 mg/kg	IV/IO/IM	not captured	standing	page 281
Nausea / vomiting	adult	12.5–50 mg	IV/IO/IM	not captured	standing	page 281
Nausea / vomiting	peds	1 mg/kg	IV/IO/IM	not captured	standing	page 281
Other	adult	12.5–50 mg	IV/IO/IM	not captured	standing	page 281
Other	peds	1 mg/kg	IV/IO/IM	not captured	standing	page 281
Procedural sedation	adult	12.5–50 mg	IV/IO/IM	not captured	standing	page 281
Procedural sedation	peds	1 mg/kg	IV/IO/IM	not captured	standing	page 281

Dopamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	2–20 mcg/kg	IV/IO	not captured	standing	page 143
Hypotension / shock	adult	5–20 mcg/kg	IV/IO	not captured	standing	page 282
Hypotension / shock	peds	1–20 mcg/kg	IV/IO	not captured	standing	page 282

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.01 mg/kg	IV/IO	not captured	standing	page 159
Anaphylaxis	adult	0.3 mg	IM	not captured	standing	page 155
Anaphylaxis	peds	0.01 mg/kg	IM	not captured	standing	page 155
Anaphylaxis	peds	0.01 mg/kg	IV/IO	not captured	standing	page 159
Asthma / bronchospasm	adult	0.01 mg/kg	SQ	not captured	standing	page 285
Bradycardia	adult	2–10 mcg	IV/IO	not captured	standing	page 144
Bradycardia	peds	0.01 mg/kg	IV/IO	not captured	standing	page 144
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	page 141
Cardiac arrest	adult	2 mg	ET	not captured	standing	page 104
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	page 141

Etomidate

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.1–0.3 mg/kg	IV/IO	not captured	standing	page 286
RSI induction	adult	0.3 mg/kg	IV/IO	not captured	standing	page 85
RSI induction	peds	0.1–0.3 mg/kg	IV/IO	not captured	standing	page 85

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	1–2 mcg/kg	IV/IO/IM	not captured	standing	page 287
Mild to moderate pain	adult	25–50 mcg	IN	not captured	standing	page 114
Mild to moderate pain	peds	0.5–1 mcg/kg	IV/IO/IM	not captured	standing	page 287

Furosemide

Indication	Population	Dose	Route	Repeat	Standing	Source
CHF / pulmonary edema	adult	0.5–1 mg/kg	IV/IO	not captured	standing	page 288
CHF / pulmonary edema	peds	2 mg/kg	IV/IO	not captured	standing	page 288

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Beta-blocker / calcium-channel-blocker overdose	adult	3–5 mg	IV/IO	not captured	standing	page 289
Beta-blocker / calcium-channel-blocker overdose	adult	3–5 mg	IV/IO	not captured	standing	page 289
Hypoglycemia	adult	1 mg	IM/SQ	not captured	standing	page 289
Hypoglycemia	peds	0.05 mg/kg	IM/SQ	not captured	standing	page 289

Heparin

Indication	Population	Dose	Route	Repeat	Standing	Source
STEMI	adult	60 unit/kg	IV	not captured	standing	page 290

Hydromorphone

Indication	Population	Dose	Route	Repeat	Standing	Source
Severe pain	adult	0.5 mg	IV/IO	not captured	standing	page 291
Severe pain	adult	1–2 mg	IM	not captured	standing	page 291
Severe pain	peds	0.015 mg/kg	IV/IO	not captured	standing	page 291
Severe pain	peds	0.015 mg/kg	IM	not captured	standing	page 291

Hydroxocobalamin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	5 g	IV	not captured	standing	page 170
Cyanide poisoning	adult	5 g	IV	not captured	standing	page 292
Cyanide poisoning	adult	5 g	IV	not captured	standing	page 170

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	500 mcg	NEB	not captured	standing	page 215
Asthma / bronchospasm	peds	0.25 mg	NEB	not captured	standing	page 215
Organophosphate poisoning	adult	500 mcg	NEB	not captured	standing	page 294
Organophosphate poisoning	peds	0.25 mg	NEB	not captured	standing	page 294

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	5–10 mg/kg	IM	not captured	standing	page 163
RSI induction	adult	1–2 mg/kg	IV	not captured	standing	page 85
RSI induction	adult	4–5 mg/kg	IM	not captured	standing	page 85
RSI induction	peds	1.5 mg/kg	IV	not captured	standing	page 85
RSI induction	peds	4–5 mg/kg	IM	not captured	standing	page 85

Ketorolac

Indication	Population	Dose	Route	Repeat	Standing	Source
Severe pain	adult	15–30 mg	IV/IO	not captured	standing	page 296
Severe pain	adult	30–60 mg	IM	not captured	standing	page 296

Labetalol

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	5–10 mg	IV	not captured	standing	page 297

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI induction	adult	1 mg/kg	IV/IO	not captured	standing	page 85
RSI induction	peds	1 mg/kg	IV/IO	not captured	standing	page 85

Lorazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	0.5–2 mg	IV/IO/IM	not captured	standing	page 325
Agitation	peds	0.1 mg/kg	IV/IO/IM	not captured	standing	page 325
Post-intubation sedation	adult	1–2 mg	IV/IO	not captured	standing	page 85
Seizure	adult	1–2 mg	IV/IO/IM	not captured	standing	page 299
Seizure	peds	0.05–0.1 mg/kg	IV/IO/IM	not captured	standing	page 299

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Eclampsia / pre-eclampsia	adult	4 g	IV/IO	not captured	standing	page 300
Other	adult	2 g	IV/IO	not captured	standing	page 300
Other	peds	25–50 mg/kg	IV/IO	not captured	standing	page 300
VF / pulseless VT	adult	1–2 g	IV/IO	not captured	standing	page 300
VF / pulseless VT	peds	25–50 mg/kg	IV/IO	not captured	standing	page 300

Methylprednisolone

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	125 mg	IV/IO	not captured	standing	page 301
Allergic reaction	peds	2 mg/kg	IV/IO	not captured	standing	page 301
Anaphylaxis	adult	125 mg	IV/IO	not captured	standing	page 159
Anaphylaxis	peds	2 mg/kg	IV/IO	not captured	standing	page 159
Asthma / bronchospasm	adult	125 mg	IV/IO	not captured	standing	page 301
Asthma / bronchospasm	peds	2 mg/kg	IV/IO	not captured	standing	page 301

Metoprolol

Indication	Population	Dose	Route	Repeat	Standing	Source
Narrow-complex tachycardia	adult	2.5–5 mg	IV/IO	not captured	standing	page 302

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	2.5–10 mg	IV/IO/IM	not captured	standing	page 304
Agitation	peds	0.1 mg/kg	IV/IO/IM	not captured	standing	page 304
Post-intubation sedation	adult	2.5–10 mg	IV/IO/IM	not captured	standing	page 85
Post-intubation sedation	peds	0.1 mg/kg	IV/IO/IM	not captured	standing	page 85
RSI induction	adult	2.5–10 mg	IV/IO	not captured	standing	page 145
RSI induction	peds	0.1 mg/kg	IV/IO	not captured	standing	page 145

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	2–6 mg	IV/IO	not captured	standing	page 138
CHF / pulmonary edema	adult	2–6 mg	IV/IO	not captured	standing	page 305
Severe pain	adult	2–6 mg	IV/IO	not captured	standing	page 305
Severe pain	peds	0.1 mg/kg	IV/IO	not captured	standing	page 305

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Opioid overdose	adult	0.4 mg	IV/IO/IM	not captured	standing	page 306
Opioid overdose	peds	0.1 mg/kg	IV/IO/IM	not captured	standing	page 306
Other	adult	0.4 mg	IV/IO/IM	not captured	standing	page 160
Other	peds	0.1 mg/kg	IV/IO/IM	not captured	standing	page 160

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.4 mg	SL	not captured	standing	page 136
CHF / pulmonary edema	adult	0.4 mg	SL	not captured	standing	page 152

Nitrous Oxide

Indication	Population	Dose	Route	Repeat	Standing	Source
Severe pain	adult	Blended mixture of 50% nitrous oxide and 50% oxygen	NEB	not captured	standing	page 307

Norepinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypotension / shock	peds	0.05–0.1 mcg/kg	IV/IO	not captured	standing	page 170
Hypotension / shock	peds	0.05–0.1 mcg/kg	IV/IO	not captured	standing	page 170

Octreotide

Indication	Population	Dose	Route	Repeat	Standing	Source
Trauma / hemorrhage	adult	25–50 mcg	IV	not captured	standing	page 311

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4 mg	PO/SL	not captured	standing	page 154
Nausea / vomiting	adult	4 mg	IV/IM	not captured	standing	page 154
Nausea / vomiting	adult	4 mg	PO/SL	not captured	standing	page 154
Nausea / vomiting	adult	4 mg	IV/IM	not captured	standing	page 154
Nausea / vomiting	peds	0.1 mg/kg	IV/IM	not captured	standing	page 154
Nausea / vomiting	peds	0.1 mg/kg	IV/IM	not captured	standing	page 154
Nausea / vomiting	peds	4 mg	PO/SL	not captured	standing	page 154
Nausea / vomiting	peds	4 mg	PO/SL	not captured	standing	page 154

Oxymetazoline

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2–3 spray	IN	not captured	standing	page 155
RSI induction	adult	2–3 spray	IN	not captured	standing	page 155

Oxytocin

Indication	Population	Dose	Route	Repeat	Standing	Source
Obstetric hemorrhage	adult	10 unit	IM	not captured	standing	page 179

Pralidoxime

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	600–1800 mg	IV/IM	not captured	standing	page 314
Nerve agent exposure	peds	25–50 mg/kg	IV/IM	not captured	standing	page 314

Promethazine

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	6.25–12.5 mg	IV/IM	not captured	standing	page 316
Nausea / vomiting	adult	6.25–12.5 mg	IV/IM	not captured	standing	page 316

Rocuronium

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.6–1.2 mg/kg	IV	not captured	standing	page 317
Other	peds	0.6 mg/kg	IV	not captured	standing	page 317
RSI induction	adult	0.6–1.2 mg/kg	IV	not captured	standing	page 317
RSI induction	peds	0.6 mg/kg	IV	not captured	standing	page 317

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	1 mEq/kg	IV/IO	not captured	standing	page 318
Cardiac arrest	peds	1 mEq/kg	IV/IO	not captured	standing	page 318
Crush injury	adult	1 mEq/kg	IV/IO	not captured	standing	page 318
Crush injury	peds	1 mEq/kg	IV/IO	not captured	standing	page 318
Hyperkalemia	adult	1 mEq/kg	IV/IO	not captured	standing	page 318
Hyperkalemia	peds	1 mEq/kg	IV/IO	not captured	standing	page 318
Tricyclic overdose	adult	1 mEq/kg	IV/IO	not captured	standing	page 318
Tricyclic overdose	peds	1 mEq/kg	IV/IO	not captured	standing	page 318

Succinylcholine

Indication	Population	Dose	Route	Repeat	Standing	Source
RSI paralysis	adult	1.5 mg/kg	IV/IO	not captured	standing	page 319
RSI paralysis	peds	1.5 mg/kg	IV/IO	not captured	standing	page 319

Tenecteplase

Indication	Population	Dose	Route	Repeat	Standing	Source
STEMI	adult	30–50 mg	IV	not captured	standing	page 320

Thiamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	100 mg	IV/IM	not captured	standing	page 160

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Trauma / hemorrhage	adult	1 g	IV	not captured	standing	page 322
Trauma / hemorrhage	peds	15 mg/kg	IV	not captured	standing	page 322

Vecuronium

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	0.1 mg/kg	IV/IO	not captured	standing	page 323
Other	peds	0.1 mg/kg	IV/IO	not captured	standing	page 323

Cite this

Pend Oreille County Emergency Medical Services, United States EMS Protocol Census. 202 dose entries, effective 2021-11-01.

https://protoquiz.com/census/agencies/pend-oreille-county-emergency-medical-services/

Outdated or wrong?

Send the current document's public URL and the listing is rebuilt from it. To have this agency removed from the census entirely, say so and it comes down the same day.